🇺🇸 FDA
Company

Elicio

Elicio Therapeutics

ELTX pharma USA

Quick answer

Elicio is a pharma company (ELTX) headquartered in BOSTON, MA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

ELI-002 7P

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

ELI-002 2P

Minimal Residual Disease

Phase 1 · small_molecule · completed

1 trials

Patents (4)

patent

US 12370245

ALK polypeptides and methods of use thereof

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12247052

CpG amphiphiles and uses thereof

Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12138301

Compounds including a mutant KRAS sequence and a lipid and uses thereof

Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11623002

ALK polypeptides and methods of use thereof

Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)